Skip to main content
SpringerLink
Log in

Control of Proliferation and Survival of C6 Glioma Cells with Modification of the Nerve Growth Factor Autocrine System

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Nerve growth factor (NGF) plays an important physiological role in differentiation and survival of various types of neurons. Glial cells and glial tumor cells synthesize multiple neurotrophic factors including NGF and secrete them into the surrounding environment; however, the mechanisms of NGF and the significance of NGF receptors have not been studied in detail. The C6 glioma cell line can synthesize NGF, respond to exogenous application of NGF and stimulate the expression of NGF receptor in an autocrine manner. In order to determine the significance of such an NGF autocrine system, the effects of exposure to exogenous NGF and deprivation of endogenous NGF were examined in a C6 glioma cell line in vitro. Exogenous NGF significantly inhibited maintenance of the cell number and thymidine incorporation. Morphological changes, including the formation of growth cones, outgrowth of processes and cellular hypertrophy, were observed, concurrently, indicating that exogenous NGF stimulated differentiation and thereby inhibited proliferation of the cells. Deprivation of endogenous NGF with anti-NGF antibody elicited a rapid decrease in cell number and thymidine incorporation, and led almost all of the cells to death within 8 days. The protein synthesis inhibitor, cycloheximide, strongly inhibited the death of NGF-deprived cells, suggesting the involvement of an active process requiring synthesis of suicide proteins. These findings imply that the NGF autocrine system plays a significant role in regulating the differentiation and survival of C6 glioma cells, similarly to neuronal cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF. Proc Natl Acad Sci USA 73: 2424-2428, 1976

    PubMed  Google Scholar 

  2. Greene LA, Shooter EM: The nerve growth factor: Biochemistry, synthesis, and mechanism of action. Ann Rev Neurosci 3: 353-402, 1980

    PubMed  Google Scholar 

  3. Kaplan DR, Martin-Zanca, Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350: 158-160, 1991

    PubMed  Google Scholar 

  4. Kaplan DR, Hempstead BL, Martin-Zanca, Chao MV: The trk proto-oncogene product:Asignal transducing receptor for nerve growth factor. Science 252: 554-558, 1991

    PubMed  Google Scholar 

  5. Johnson EM Jr, Gorin PD, Brandeis LD, Pearson J: Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210: 916-918, 1980

    PubMed  Google Scholar 

  6. Levi-Montalcini R, Booker B: Destruction of sympathetic ganglia in mammals by an antiserum to the nerve-growth promoting factor. Proc Natl Acad SciUSA 42: 384-391, 1960

    Google Scholar 

  7. Martin DP, Schmidt RE, Distefano PS, Lowry OH, Capter JG, Johonson EM Jr: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829-844, 1988

    PubMed  Google Scholar 

  8. Marushige Y, Marushige K, Okazaki DL, Koestner A: Cytoskeletal reorganization induced by nerve growth factor and glial maturation factor in anaplastic glioma cells. Anticancer Res 9: 1143-1148, 1989

    PubMed  Google Scholar 

  9. Yankner BA, Shooter EM: The biology and mechanism of action of nerve growth factor. Ann Rev Biochem 51: 845-868, 1984

    Google Scholar 

  10. Bernd P: Characterization of nerve growth factor binding to cultured neural crest cells: Evidence of an early developmental form of the NGF receptor. Dev Biol 115: 415-424, 1986

    PubMed  Google Scholar 

  11. Greiner CAM, Lloyd AT, Guroff G: Ontogeny of the nerve growth factor receptor in primary cultures of neural crest cells. Dev Brain Res 26: 145-150, 1986

    Google Scholar 

  12. Kumar S, Huber J, Pena LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J: Characterization of functional nerve growth factor-receptors in a CNS glial cell line: Monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. J Neurosci Res 27: 408-417, 1990

    PubMed  Google Scholar 

  13. MullerHW, Beckh S, SeifertW: Neurotrophic factor for central neurons. Proc Natl Acad Sci USA 86: 1248-1252, 1984

    Google Scholar 

  14. Westermann R, Hardung M, Meyer DK, Ehrhard P, Otten U, Unsicker K: Neurotrophic factors released by C6 glioma cells. J Neurochem 50: 1747-1758, 1988

    PubMed  Google Scholar 

  15. Zurn AD, Nick H, Monard D: A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev Neurosci 10: 17-24, 1988

    PubMed  Google Scholar 

  16. LoweWL Jr, MeyerT, KarpenCW, Lorentzen LR: Regulation of insulin-like growth factor I production in rat C6 glioma cells: Possible role as an autocrine/paracrine growth factor. Endocrinology 130: 2683-2691, 1992

    PubMed  Google Scholar 

  17. Hsu SN, Raine L, Fanger H: The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577, 1981

    PubMed  Google Scholar 

  18. Ross AH, Grob P, Bothwell M, Elder DE, Ernst CS, Marano N, Ghrist BFD, Slemp CC, Herlyn M, Atkinson B, Koprowski H: Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 81: 6681-6685, 19

  19. Marushige Y, Raiju NR, Marushige K, Koestner A: Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glial maturation factor. Cancer Res 47: 4109-4115, 1987

    PubMed  Google Scholar 

  20. Thoenen H: The changing scene of neurotrophic factors. Trends Neurosci 14: 165-170, 1991

    PubMed  Google Scholar 

  21. Boonstra J, Mummery CL, Feyen A, de Hoog WJ, van der Saag PT, de laat SW: Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J Cell Physiol 131: 409-417, 1987

    PubMed  Google Scholar 

  22. Koike T: Molecular and cellular mechanism of neuronal degeneration caused by nerve growth factor deprivation approached through PC12 cell culture. Prog Neuro-Psychopharmacol Biol-Psychiat 16: 107-115, 1992

    Google Scholar 

  23. Jensen LM, Zhang Y, Shooter EM: Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivationinduced apoptosis in human neuroblastoma cells. J BiolChem 267: 19325-19333, 1992

    Google Scholar 

  24. Li XN, Du ZW, Huang Q: Modulation effect of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells. J Neurosurg 84: 831-838, 1996.

    PubMed  Google Scholar 

  25. Li XN, Du ZW, Huang Q, Wu JQ: Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells. Neurosurgery 40: 1250-1259, 1997

    PubMed  Google Scholar 

  26. Linskey ME, Gilbert MR: Glial differentiation:Areviewwith implications for new directions in neuro-oncology. Neurosurgery 36: 1-22, 1995

    PubMed  Google Scholar 

  27. Rutka JT, Smith SL: Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res 53: 3624-3631, 1993

    PubMed  Google Scholar 

  28. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB, Becker LE: Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion and adhesion of human astrocytoma cells. Cancer Res 54: 3267-3272, 1994

    PubMed  Google Scholar 

  29. Tanaka S, Nagashima T, Manaka S, Hori T, Yasumoto S: Growth suppression and astrocytic differentiation of glial cells by interleukin-1. J Neurosurg 81: 402-410, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan

    Takao Watanabe, Yoichi Katayama, Sigeyoshi Kimura & Atsuo Yoshino

Authors
  1. Takao Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoichi Katayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sigeyoshi Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atsuo Yoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, T., Katayama, Y., Kimura, S. et al. Control of Proliferation and Survival of C6 Glioma Cells with Modification of the Nerve Growth Factor Autocrine System. J Neurooncol 41, 121–128 (1999). https://doi.org/10.1023/A:1006127624487

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006127624487

Search

Navigation